Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Orthopedic outcome studies and cost issues.

Louis M Aledort1

  • 1Mount Sinai School of Medicine, New York, New York 10029-6574, USA. louis.aledort@mssm.edu

Seminars in Thrombosis and Hemostasis
|March 18, 2003
PubMed
Summary

Standard therapy involved on-demand treatment. This study reviews clinical experiences with prophylactic therapy and ongoing research to define optimal treatment strategies, including cost analysis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Emicizumab in Hemophilia A. Reply.

The New England journal of medicine·2020
Same author

Deaths Associated with Emicizumab in Patients with Hemophilia A.

The New England journal of medicine·2019
Same author

The ongoing imperative for immune tolerance induction in inhibitor management.

Haemophilia : the official journal of the World Federation of Hemophilia·2019
Same author

Emicizumab Prophylaxis in Hemophilia A with Inhibitors.

The New England journal of medicine·2017
Same author

Treatment of Congenital Thrombotic Thrombocytopenia Purpura: A New Paradigm.

Journal of pediatric hematology/oncology·2017
Same author

A randomized trial of avatrombopag, an investigational thrombopoietin-receptor agonist, in persistent and chronic immune thrombocytopenia.

Blood·2014

Area of Science:

  • Medical treatment strategies
  • Clinical research and experience

Background:

  • Historically, on-demand therapy was the standard for managing certain medical conditions.
  • A shift towards prophylactic approaches is being explored globally.

Purpose of the Study:

  • To present results from international clinical experiences using a prophylactic therapy approach.
  • To discuss ongoing experimental designs for optimizing therapy.
  • To analyze the costs associated with current prophylaxis regimens.

Main Methods:

  • Review of clinical experience data from multiple countries.
  • Analysis of ongoing experimental designs for therapy optimization.
  • Cost evaluation of current prophylaxis regimens.

Main Results:

  • Clinical data from various countries support a prophylactic approach.
  • Experimental designs are actively defining optimal therapeutic strategies.
  • Cost implications of prophylaxis are being assessed.

Conclusions:

  • Prophylactic therapy shows promise and is supported by international clinical experience.
  • Further research is needed to establish optimal therapeutic protocols.
  • Economic factors are a key consideration in therapy selection.

Related Experiment Videos